
Pharma stocks have recently emerged as one of Wall Street's hottest trades, with November marking a striking inflection point few had expected.
In an exclusive interview with Benzinga on Wednesday, Tema ETFs founder and CEO Maurits Pot said the pharma sector is entering a new phase of structural change, which may soon redefine how we live with, or even cure, cancer.